Curaleaf and Jupiter Research Launch QMID Medical Cannabis Inhalation Device in Australia

Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in partnership with Jupiter Research LLC, announced that its Que Medical Inhalation Dev...

October 05, 2026 | Monday | News
Egle Therapeutics Reports Phase 1 Data for Treg-Selective EGL-003 in Autoimmune Disease

EGL-003, a selective IL-2 agonist, was well tolerated across all four dose cohorts. EGL-003 produced selective, dose-dependent Treg expansion without am...

October 01, 2026 | Thursday | News
Caspian Therapeutics Reports KO-7246 Data in Type 1 and Type 2 Diabetes

– KO-7246 regenerated functional β-cell mass and produced durable glycemic control in Type 1 and Type 2 diabetes models – – KO-7246...

September 30, 2026 | Wednesday | News
Aptar Pharma and Massachusetts General Hospital Partner to Advance Nose-to-Brain Drug Delivery

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, announced that it has...

September 16, 2026 | Wednesday | News
Elixir Medical Secures Japan Approval for DynamX Sirolimus-Eluting Coronary Bioadaptor System

Elixir Medical (Milpitas, Calif., and Tokyo) announced that its DynamX® Sirolimus-Eluting Coronary Bioadaptor System for the treatment of cor...

September 16, 2026 | Wednesday | News
Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered Rentosertib for IPF

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced that it has dosed the first patien...

September 11, 2026 | Friday | News
Nanox Expands U.S. Distribution Network Through New England Partnership

Expands Nanox’s growing U.S. distribution network with a leading New England-based medical imaging provider Nano-X Imaging Ltd. (“Nanox&rdqu...

September 08, 2026 | Tuesday | News
Telix Completes BiPASS Phase 3 Enrollment, Advances PSMA-PET Imaging for Earlier Prostate Cancer Diagnosis

Telix Pharmaceuticals Limited announced completion of patient enrollment in the Phase 3 BiPASS™ study of its commercial PSMA-PET imaging agent...

September 03, 2026 | Thursday | News
Stryker to Acquire ZuriMED, Expanding Rotator Cuff Augmentation Portfolio

Stryker, a global leader in medical technologies, announced it has signed a definitive agreement to acquire ZuriMED, a privately held company and develop...

September 02, 2026 | Wednesday | News
NexLife Expands Compounded GLP-1 Program With Four Protocols Under Flat-Rate Pricing Model

NexLife, a LegitScript-certified, physician-led telehealth platform, announced that its compounded GLP-1 program now spans four protocols under a single ...

September 02, 2026 | Wednesday | News
Qosina Launches Regulatory Services to Support Medical Device Compliance

Qosina, a global supplier of single-use components for the medical device and life sciences industries, today announced the launch of Qosina Regulatory S...

August 25, 2026 | Tuesday | News
QT Imaging Advances Quantitative Breast Imaging With 3D, Radiation-Free Ultrasound

  As breast imaging continues to evolve toward more quantitative and patient-centred approaches, QT Imaging is developing a three-dimensional ultraso...

August 25, 2026 | Tuesday | Interview
Milestone Pharmaceuticals Enrolls First Patient in Phase 3 Trial of Etripamil for AFib-RVR

Milestone® Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medi...

August 24, 2026 | Monday | News
Smith+Nephew Introduces FLOW FLEXTEND COBLATION Wand for Hip Procedures

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces a breakthrough in RF resection technology for hip with its new FLOW FLE...

August 19, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close